# Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes

> **NCT00283309** · PHASE4 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Mood
- Memory Deficit

## Interventions

- **DRUG:** Memantine
- **DRUG:** Riluzole

## Key facts

- **NCT ID:** NCT00283309
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Study finished enrollment but data was never sent for publishing.
- **Last updated:** 2013-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283309, "Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00283309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*